ORCHPHARMA.NSORCHPHARMA.NSNSE
Loading
SG&A Expenses Over TimeContracting
Percentile Rank67
3Y CAGR+28.7%
5Y CAGR+13.3%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+28.7%/yr
vs -1.6%/yr prior
5Y CAGR
+13.3%/yr
Recent acceleration
Acceleration
+30.2pp
Accelerating
Percentile
P67
Within normal range
vs 5Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$492.37M-44.2%
2025$882.37M+173.3%
2024$322.83M+39.6%
2023$231.23M-25.2%
2022$309.03M+17.3%
2021$263.51M-15.9%
2020$313.14M+27.1%
2019$246.38M-37.5%
2018$394.00M-15.9%
2017$468.47M-